Data from EMC - Curated by Toby Galbraith - Last updated 11 July 2017

Licensing authority

EMA (European Medicines Agency)

Indication(s)

Treatment of patients with moderate to severe Alzheimer’s disease.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Airway Disease

The Airway Disease Learning Zone is an area where you can access the information about VisionAir and the upcoming live broadcast. A video presentation will be available from EAACI 2017 entitled 'Personalising Clinical Management in Severe Asthma'. The Inhalation Technology page will feature video presentations from the live broadcast soon. 

Visit Airway Disease


Hyperammonaemia

Hyperammonaemia can result in serious neurological damage or death. Could you recognise the signs and symptoms?

Visit Hyperammonaemia


Related Content

More information

Category Value
Agency product number EMEA/H/C/002680
Orphan designation No
Date First Approved 22-04-2013
Type Medicinal product subject to restricted medical prescription
Marketing authorisation holder Actavis Group PTC ehf.